| UHC Commercial Medical & Drug | Visual Information Processing Evaluation and Orthoptic and Vision Therapy - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Vyjuvek® (Beramagene Geperpavec-Svdt) - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Walkers - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Whole Exome and Whole Genome Sequencing (Non-Oncology Conditions) - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Commercial Medical & Drug | Xiaflex® (Collagenase Clostridium Histolyticum) - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Ambulance Services - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Apheresis - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Autologous Cellular Therapy - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Beds and Mattresses - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Botulinum Toxins A and B - Commercial Medical Benefit Drug Policy | 2026-01-01 |